The only technical publication devoted exclusively to readers involved in development and production of orally inhaled and nasal drug products (OINDPs).


Application of biological models to inform research and development of inhalation products

Excipient enhanced growth (EEG): Expanding delivery options for the treatment of lung diseases

Back Pages:

Nestlé reconsidering only FDA-approved peanut allergy drug for children due to slow uptake

Food allergy bravery clinic helps children overcome anxiety

Cross-Industry Organizations:

The International Society for Aerosols in Medicine (ISAM): 2022 highlights
and a preview of 2023 activities

Non-reducing sugars as excipients in spray-dried powders for inhalation

Considerations for the design and development of connected inhalation systems

Conference Preview:

Previewing RDD® Europe 2023

From the Archive:

Interaction of nanomaterials at the air-liquid interface of the lung


Industry Organizations

Inhalation 1-2-3

Reference & Buyer’s Resource

Editorial Advisory Board




White Papers